Regulation of vascular endothelial growth factor expression by homeodomain-interacting protein kinase-2
2008
How HIPK2 Affects VEGF Levels in Tumor Cells
publication
Evidence: moderate
Author Information
Author(s): Puca Rosa, Nardinocchi Lavinia, D'Orazi Gabriella
Primary Institution: Regina Elena Cancer Institute, Rome, Italy
Hypothesis
Does HIPK2 overexpression down-regulate VEGF levels through β-catenin regulation?
Conclusion
HIPK2 overexpression decreases VEGF levels in tumor cells, suggesting it could be a target for anti-tumor therapies.
Supporting Evidence
- HIPK2 overexpression reduced VEGF mRNA levels in tumor cells.
- The downregulation of VEGF was linked to HIPK2's ability to regulate β-catenin.
- HIPK2's effect on β-catenin was independent of p53 and GSK-3β activities.
Takeaway
HIPK2 is like a superhero that helps stop cancer cells from making a substance that helps tumors grow by breaking down a bad guy called β-catenin.
Methodology
The study used luciferase assays, RT-PCR, and western blotting to evaluate the effects of HIPK2 on VEGF and β-catenin levels.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website